| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.132 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
1.132 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.132 |
Evidence |
|
| ZNF267 |
ZNF267: Zinc finger protein 267 |
ZNF174 |
ZNF174, ZSCAN8: Zinc finger protein 174 |
1.132 |
Evidence |
|
| IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
IL2 |
IL2: Interleukin 2 |
1.132 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
RYR2 |
RYR2: Ryanodine receptor 2 |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.132 |
Evidence |
|
| HES6 |
HES6: Transcription cofactor HES-6 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
1.132 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.132 |
Evidence |
|
| TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.132 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
1.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
1.132 |
Evidence |
|
| PRL |
PRL: Prolactin precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
| DLK1 |
DLK1, DLK: Delta-like protein precursor |
JAG2 |
JAG2: Jagged-2 precursor |
1.132 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
1.132 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.132 |
Evidence |
|
| PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
1.132 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.132 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
1.132 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.132 |
Evidence |
|